As of 2025-04-22, the Intrinsic Value of Vincerx Pharma Inc (VINC) is -28.75 USD. This VINC valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.13 USD, the upside of Vincerx Pharma Inc is -21,668.98%.
Based on its market price of 0.13 USD and our intrinsic valuation, Vincerx Pharma Inc (VINC) is overvalued by 21,668.98%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -28.75 - -28.75 | -28.75 | -21,668.98% |
| P/E | (51.06) - (74.37) | (64.81) | -48715.9% |
| DDM - Stable | (17.05) - (49.50) | (33.27) | -25061.0% |
| DDM - Multi | (13.76) - (32.90) | (19.62) | -14815.5% |
| Market Cap (mil) | 1.44 |
| Beta | 0.26 |
| Outstanding shares (mil) | 10.79 |
| Enterprise Value (mil) | -3.55 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.26% |
| Cost of Debt | 5.00% |
| WACC | 7.96% |